Tech Company Financing Transactions
Starlight Cardiovascular Funding Round
Bird B participated in a $9.5 million Series A funding round for Starlight Cardiovascular. The round was announced by the company on 10/5/2022.
Transaction Overview
Company Name
Announced On
10/5/2022
Transaction Type
Venture Equity
Amount
$9,480,000
Round
Series A
Investors
Bird B (Lead Investor)
Proceeds Purpose
The company intends to use the funds to progress development of its portfolio of pediatric interventional cardiology devices.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9710 Scranton Rd 100
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Starlight Cardiovascular is developing much needed tools and devices to treat pediatric congenital heart defects (CHDs). Approximately 1.3 million babies are born each year with a CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Beverly Tang
Co-Founder
Carl Berke
Co-Founder
Tom Duerig
Co-Founder
Attila Meretei
Co-Founder
Pedro Nido
Vice President
Mark Juravic
Vice President
Kathryn Olson
Browse more venture capital transactions:
Prev: 10/5/2022: Halp venture capital transaction
Next: 10/5/2022: PredictionStrike venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs